For various cancers, serum CXCL8 is a potential biomarker, such as for gastric cancer [39], pancreatic cancer [40], colorectal cancer [41], and non-small-cell lung cancer [42]. This evidence concerns the gene CXCL8 and non-small cell lung carcinoma.